Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Willize E. van der Starre"'
Autor:
Janneke E. Stalenhoef, Willize E. van der Starre, Albert M. Vollaard, Ewout W. Steyerberg, Nathalie M. Delfos, Eliane M.S. Leyten, Ted Koster, Hans C. Ablij, Jan W. van’t Wout, Jaap T. van Dissel, Cees van Nieuwkoop
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background There is a lack of severity assessment tools to identify adults presenting with febrile urinary tract infection (FUTI) at risk for complicated outcome and guide admission policy. We aimed to validate the Prediction Rule for Admiss
Externí odkaz:
https://doaj.org/article/70ad9d58b8d7405cbd89646cd12cda46
Autor:
Cees van Nieuwkoop, Willize E. van der Starre, Janneke E. Stalenhoef, Anna M. van Aartrijk, Tanny J. K. van der Reijden, Albert M. Vollaard, Nathalie M. Delfos, Jan W. van ’t Wout, Jeanet W. Blom, Ida C. Spelt, Eliane M. S. Leyten, Ted Koster, Hans C. Ablij, Martha T. van der Beek, Mirjam J. Knol, Jaap T. van Dissel
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background In adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking. Methods A randomized placebo-controlled, double-blind, non-infe
Externí odkaz:
https://doaj.org/article/4dfae37b5f7f4663b5d59b47ebae3229
Autor:
Willize E van der Starre, Cees van Nieuwkoop, Uginia Thomson, Marleen S M Zijderveld-Voshart, Jan Pieter R Koopman, Tanny J K van der Reijden, Jaap T van Dissel, Esther van de Vosse
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121302 (2015)
Objective/purposeFebrile urinary tract infection (UTI) is a common bacterial disease that may lead to substantial morbidity and mortality especially among the elderly. Little is known about biomarkers that predict a complicated course. Our aim was to
Externí odkaz:
https://doaj.org/article/80a023e39edf4cf8833b8923b8b5f5fe
Autor:
Janneke E. Stalenhoef, Darius Cameron Wilson, Cees van Nieuwkoop, Tanny J. K. van der Reijden, Ted Koster, Eliane M. S. Leyten, Hans C. Ablij, Jaap T. van Dissel, Nathalie M Delfos, Johannes Jan Willem van 't Wout, Willize E. van der Starre
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
A reduction in duration of antibiotic therapy is crucial in minimizing the development of antimicrobial resistance, drug-related side effects and health care costs. The minimal effective duration of antimicrobial therapy for febrile urinary tract inf
Autor:
Cees van Nieuwkoop, Nathalie M Delfos, Willize E. van der Starre, Janneke E. Stalenhoef, Ted Koster, Albert M Vollaard, Jaap T. van Dissel, Hans C. Ablij, Ewout W. Steyerberg, Eliane M. S. Leyten, Jan W van't Wout
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Infectious Diseases, 17
BMC Infectious Diseases
BMC Infectious Diseases, 17:400. BioMed Central Ltd.
BMC Infectious Diseases, 17
BMC Infectious Diseases
BMC Infectious Diseases, 17:400. BioMed Central Ltd.
Background There is a lack of severity assessment tools to identify adults presenting with febrile urinary tract infection (FUTI) at risk for complicated outcome and guide admission policy. We aimed to validate the Prediction Rule for Admission polic
Autor:
Jaap T. van Dissel, Ekaterina Nevedomskaya, André M. Deelder, Oleg A. Mayboroda, Tiziana Pacchiarotta, Rico J. E. Derks, Willize E. van der Starre
Publikováno v:
Analyst, 140(8), 2834-2841
Urinary tract infection (UTI) is among the most common bacterial infections worldwide. The understanding of the physiological mechanisms affected by UTI may need modern integrative '-omics' technologies, and metabolomics in particular. Here we presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b45fb5c4d4db1d3b14392db94171f2a
http://hdl.handle.net/1887/101011
http://hdl.handle.net/1887/101011
Publikováno v:
Current Infectious Disease Reports
Although febrile urinary tract infections (UTIs) are relatively common in adults, data on optimal treatment duration are limited. Randomized controlled trials specifically addressing the elderly and patients with comorbidities have not been performed
Autor:
Jaap T. van Dissel, Uginia Thomson, Marleen S. M. Zijderveld-Voshart, Tanny J. K. van der Reijden, Willize E. van der Starre, Esther van de Vosse, Jan Pieter R. Koopman, Cees van Nieuwkoop
Publikováno v:
PLoS ONE, 10(3)
PLoS ONE
PLoS ONE, Vol 10, Iss 3, p e0121302 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 3, p e0121302 (2015)
Objective/purposeFebrile urinary tract infection (UTI) is a common bacterial disease that may lead to substantial morbidity and mortality especially among the elderly. Little is known about biomarkers that predict a complicated course. Our aim was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd68d9c3909134cfb8887c07b743be4
https://hdl.handle.net/1887/107780
https://hdl.handle.net/1887/107780
Autor:
Hans C. Ablij, Eliane M. S. Leyten, Cees van Nieuwkoop, Ted Koster, Ida C. Spelt, Willize E. van der Starre, Jeanet W. Blom, Albert M Vollaard, Hanneke Borgdorff, Jan W. van ’t Wout, Jaap T. van Dissel, Nathalie M Delfos
Publikováno v:
Diabetes Care
Diabetes Care, 36(12), E193-E194
Diabetes Care, 36(12), E193-E194
Diabetes is considered a risk factor for acquisition of febrile urinary tract infection (UTI) (1,2), but there is a lack of information on the association of diabetes with the subsequent course of disease and its outcome. We performed a prospective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca352e8553e9a1fe67d84a69407936b
https://doi.org/10.2337/dc13-0903
https://doi.org/10.2337/dc13-0903
Autor:
Rogier M. Bertina, Jaap T. van Dissel, Cees van Nieuwkoop, Margot E T Tesselaar, Patricia Garcia Rodriguez, Willize E. van der Starre, F. J. Sherida H. Woei-A-Jin, Susanne Osanto
Publikováno v:
Thrombosis Research
Thrombosis Research, 133(5), 799-803
Thrombosis Research, 133(5), 799-803
Inhibition of tissue factor, the primary initiator of coagulation in sepsis, attenuates morbidity in primates infused with Escherichia coli. In a human endotoxemia model, microparticles expressing procoagulant TF (MP-TF) are released in blood concurr